Identification of immunologic and clinical characteristics that predict inflammatory response to C. Novyi-NT bacteriolytic immunotherapy

BACKGROUND: Clostridium novyi-NT (CNV-NT), has shown promise as a bacterolytic therapy for solid tumors in mouse models and in dogs with naturally developing neoplasia. Factors that impact the immunologic response to therapy are largely unknown. The goal of this pilot study was to determine if plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: DeClue, Amy E., Axiak-Bechtel, Sandra M., Zhang, Yan, Saha, Saurabh, Zhang, Linping, Tung, David D., Bryan, Jeffrey N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879919/
https://www.ncbi.nlm.nih.gov/pubmed/29606140
http://dx.doi.org/10.1186/s12917-018-1424-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879919/
https://www.ncbi.nlm.nih.gov/pubmed/29606140
http://dx.doi.org/10.1186/s12917-018-1424-1

Ejemplares similares